Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent ...

H.C. Wainwright maintains a Buy rating on Invivyd (IVVD) with a $10 price target after the FDA rejected its submission to expand Pemgarda’s ...

Invivyd's bid to expand Pemgarda's EUA for COVID-19 treatment was denied by the FDA. The company will share new data on ...

Monday said that its request to expand the existing emergency use authorization of PEMGARDA (pemivibart) to include treatment of mild-to-moderate COVID-19 for immunocompromised persons who have no ...

The commercial-stage biopharmaceutical company said its request to expand the existing emergency use authorization of the drug, also called pemivibart, to treat mild-to-moderate Covid-19 in more ...

Invivyd (IVVD) announced that Invivyd’s request to expand the existing emergency use authorization for pre-exposure prophylaxis of COVID-19 EUA ...

Physicians and other medical providers will tell you that PA is out of control and has transcended any legitimate rationale for its establishment.

The U.S. Army Corps of Engineers on Thursday said it is revising a list of more than 600 energy and other infrastructure ...

In the face of the alarming number of opioid-related deaths in the U.S., there have been national efforts to increase emergency clinician prescribing of buprenorphine, a medication used to treat ...

The Army Corps of Engineers has identified over 600 energy and other infrastructure projects that could be fast-tracked under ...

View the Release of Medical Information Policy If other individuals or agencies have provided confidential information to Student Health Services, you cannot use the authorization form to re-release ...